# COSMOS HEALTH INC. (COSM) · Edgar & Edgarette company card

> Cosmos Health (COSM) grew revenue 19.9% in FY2025 to $65 million, operating margin -25.6% against a 1.4% median for drugs, proprietaries & druggists' sundries, equity 28.1% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1474167 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/COSM) · [JSON](https://www.pops4.com/boards/company/COSM.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $65M |
| Revenue growth, 1 year | 19.9% |
| Revenue growth per year | 3.8% |
| Operating margin | -25.6% (prior year -28.6%) |
| Net margin | -29.3% |
| Operating cash flow | −$8M |
| Capital spending | $55,675 |
| Free cash flow | −$9M |
| Cash | $715,674 |
| Long-term debt | $4M |
| Total assets | $65M |
| Total equity | $18M |
| Equity ÷ assets | 28.1% |
| Return on equity | -103.9% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -7.92 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -3.24 (below the −1.78 line)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late annual report notice, late quarterly report notice in the last 12 months; operating cash flow was negative; operating loss: a margin of -25.6% in FY2025; revenue is hard to predict: its 80% range is ±34%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $65.3M (FY2025), total debt $3.8M. Experience: revenue up 19.9% on the year, up 3.8% a year over 4 years; operating margin -25.6%, up from -28.6%. Soundness: equity 28.1% of assets, return on equity -103.9%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $50.6M and $103.4M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $52.0M to $100.8M. A statistical range, not company guidance. Against peers (30 filers, $50M+ revenue, its industry group): operating margin -25.6% against a 1.4% median; growth 19.9% against 0.9%.

Range logged 2026-09-27, receipt dea6d86ee55bec86, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-K Late annual report notice: 1, latest 2026-04-01 ([filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226001897/0001477932-26-001897-index.htm))
- Item 3.01 Exchange listing notice or transfer: 1, latest 2025-12-18 ([filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793225009040/0001477932-25-009040-index.htm))
- Item NT 10-Q Late quarterly report notice: 2, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226005084/0001477932-26-005084-index.htm))
- Item 5.02 Director or officer change: 1, latest 2026-07-16 ([filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226004357/0001477932-26-004357-index.htm))

## Recent filings

- 8-K · filed 2026-11-10 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226006793/0001477932-26-006793-index.htm)
- 8-K · filed 2026-10-22 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226006396/0001477932-26-006396-index.htm)
- 8-K · filed 2026-10-09 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226006158/0001477932-26-006158-index.htm)
- 8-K · filed 2026-08-20 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226005195/0001477932-26-005195-index.htm)
- 10-Q · filed 2026-08-18 · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226005146/0001477932-26-005146-index.htm)
- 8-K · filed 2026-07-16 · 3.03 Material Modifications to Rights of Security Holders; 5.02 Departure or Election of Directors; Appointment of Officers; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1474167/000147793226004357/0001477932-26-004357-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001474167.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1474167

## Cite

POPS4, Edgar & Edgarette: COSMOS HEALTH INC. (COSM) company card, from the company's own SEC filings, accessed 2026-11-12, https://www.pops4.com/boards/company/COSM. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.